Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson's disease: 18-month results from a phase 1 study Meeting Abstract

  

Authors:	Fasano, A.; Henchcliffe, C.; Sarva, H.; Lozano, A.; Kalia, S.; Yu, K. K. H.; Brennan, C.; Stemple, W.; Abid, N.; Yountz, M.; Enayetallah, A.; Lampron, A.; Tabar, V.
Abstract Title:	Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson's disease: 18-month results from a phase 1 study
Meeting Title:	XXIX IAPRD World Congress on Parkinson's Disease and Related Disorders (IAPRD 2024)
Journal Title:	Parkinsonism & Related Disorders
Volume:	122
Meeting Dates:	2024 May 19-22
Meeting Location:	Lisbon, Portugal
ISSN:	1353-8020
Publisher:	Elsevier Science, Inc.
Date Published:	2024-05-01
Start Page:	106107
Language:	English
DOI:	10.1016/j.parkreldis.2024.106129
PROVIDER:	EBSCOhost
PROVIDER:	cinahl plus with full text
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=rzh&AN=177374606&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: O_23 -- Source: CINAHL Plus with Full Text

https://synapse.mskcc.org/synapse/works/has_related_data_chk/216768